author_facet Contu, A
Olmeo, N
Piro, S
Sabbatini, R
Depenni, R
Silingardi, V
Zaniboni, A
Meriggi, F
Donati, D
Maestri, A
Tateo, S
Carpi, A
Campora, E
Coria, B
Riva, E
Barbieri, P
Contu, A
Olmeo, N
Piro, S
Sabbatini, R
Depenni, R
Silingardi, V
Zaniboni, A
Meriggi, F
Donati, D
Maestri, A
Tateo, S
Carpi, A
Campora, E
Coria, B
Riva, E
Barbieri, P
author Contu, A
Olmeo, N
Piro, S
Sabbatini, R
Depenni, R
Silingardi, V
Zaniboni, A
Meriggi, F
Donati, D
Maestri, A
Tateo, S
Carpi, A
Campora, E
Coria, B
Riva, E
Barbieri, P
spellingShingle Contu, A
Olmeo, N
Piro, S
Sabbatini, R
Depenni, R
Silingardi, V
Zaniboni, A
Meriggi, F
Donati, D
Maestri, A
Tateo, S
Carpi, A
Campora, E
Coria, B
Riva, E
Barbieri, P
Anti-Cancer Drugs
A comparison of the antiemetic efficacy and safety of intramuscular and intravenous formulations of granisetron in patients receiving moderately emetogenic chemotherapy
Cancer Research
Pharmacology (medical)
Pharmacology
Oncology
author_sort contu, a
spelling Contu, A Olmeo, N Piro, S Sabbatini, R Depenni, R Silingardi, V Zaniboni, A Meriggi, F Donati, D Maestri, A Tateo, S Carpi, A Campora, E Coria, B Riva, E Barbieri, P 0959-4973 Ovid Technologies (Wolters Kluwer Health) Cancer Research Pharmacology (medical) Pharmacology Oncology http://dx.doi.org/10.1097/00001813-199510000-00004 A comparison of the antiemetic efficacy and safety of intramuscular and intravenous formulations of granisetron in patients receiving moderately emetogenic chemotherapy Anti-Cancer Drugs
doi_str_mv 10.1097/00001813-199510000-00004
facet_avail Online
finc_class_facet Medizin
Chemie und Pharmazie
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5Ny8wMDAwMTgxMy0xOTk1MTAwMDAtMDAwMDQ
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5Ny8wMDAwMTgxMy0xOTk1MTAwMDAtMDAwMDQ
institution DE-15
DE-Pl11
DE-Rs1
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-D161
DE-Gla1
DE-Zi4
imprint Ovid Technologies (Wolters Kluwer Health), 1995
imprint_str_mv Ovid Technologies (Wolters Kluwer Health), 1995
issn 0959-4973
issn_str_mv 0959-4973
language English
mega_collection Ovid Technologies (Wolters Kluwer Health) (CrossRef)
match_str contu1995acomparisonoftheantiemeticefficacyandsafetyofintramuscularandintravenousformulationsofgranisetroninpatientsreceivingmoderatelyemetogenicchemotherapy
publishDateSort 1995
publisher Ovid Technologies (Wolters Kluwer Health)
recordtype ai
record_format ai
series Anti-Cancer Drugs
source_id 49
title A comparison of the antiemetic efficacy and safety of intramuscular and intravenous formulations of granisetron in patients receiving moderately emetogenic chemotherapy
title_unstemmed A comparison of the antiemetic efficacy and safety of intramuscular and intravenous formulations of granisetron in patients receiving moderately emetogenic chemotherapy
title_full A comparison of the antiemetic efficacy and safety of intramuscular and intravenous formulations of granisetron in patients receiving moderately emetogenic chemotherapy
title_fullStr A comparison of the antiemetic efficacy and safety of intramuscular and intravenous formulations of granisetron in patients receiving moderately emetogenic chemotherapy
title_full_unstemmed A comparison of the antiemetic efficacy and safety of intramuscular and intravenous formulations of granisetron in patients receiving moderately emetogenic chemotherapy
title_short A comparison of the antiemetic efficacy and safety of intramuscular and intravenous formulations of granisetron in patients receiving moderately emetogenic chemotherapy
title_sort a comparison of the antiemetic efficacy and safety of intramuscular and intravenous formulations of granisetron in patients receiving moderately emetogenic chemotherapy
topic Cancer Research
Pharmacology (medical)
Pharmacology
Oncology
url http://dx.doi.org/10.1097/00001813-199510000-00004
publishDate 1995
physical 652-656
description
container_issue 5
container_start_page 652
container_title Anti-Cancer Drugs
container_volume 6
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792333757088268291
geogr_code not assigned
last_indexed 2024-03-01T14:17:50.144Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=A+comparison+of+the+antiemetic+efficacy+and+safety+of+intramuscular+and+intravenous+formulations+of+granisetron+in+patients+receiving+moderately+emetogenic+chemotherapy&rft.date=1995-10-01&genre=article&issn=0959-4973&volume=6&issue=5&spage=652&epage=656&pages=652-656&jtitle=Anti-Cancer+Drugs&atitle=A+comparison+of+the+antiemetic+efficacy+and+safety+of+intramuscular+and+intravenous+formulations+of+granisetron+in+patients+receiving+moderately+emetogenic+chemotherapy&aulast=Barbieri&aufirst=P&rft_id=info%3Adoi%2F10.1097%2F00001813-199510000-00004&rft.language%5B0%5D=eng
SOLR
_version_ 1792333757088268291
author Contu, A, Olmeo, N, Piro, S, Sabbatini, R, Depenni, R, Silingardi, V, Zaniboni, A, Meriggi, F, Donati, D, Maestri, A, Tateo, S, Carpi, A, Campora, E, Coria, B, Riva, E, Barbieri, P
author_facet Contu, A, Olmeo, N, Piro, S, Sabbatini, R, Depenni, R, Silingardi, V, Zaniboni, A, Meriggi, F, Donati, D, Maestri, A, Tateo, S, Carpi, A, Campora, E, Coria, B, Riva, E, Barbieri, P, Contu, A, Olmeo, N, Piro, S, Sabbatini, R, Depenni, R, Silingardi, V, Zaniboni, A, Meriggi, F, Donati, D, Maestri, A, Tateo, S, Carpi, A, Campora, E, Coria, B, Riva, E, Barbieri, P
author_sort contu, a
container_issue 5
container_start_page 652
container_title Anti-Cancer Drugs
container_volume 6
description
doi_str_mv 10.1097/00001813-199510000-00004
facet_avail Online
finc_class_facet Medizin, Chemie und Pharmazie
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5Ny8wMDAwMTgxMy0xOTk1MTAwMDAtMDAwMDQ
imprint Ovid Technologies (Wolters Kluwer Health), 1995
imprint_str_mv Ovid Technologies (Wolters Kluwer Health), 1995
institution DE-15, DE-Pl11, DE-Rs1, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-D161, DE-Gla1, DE-Zi4
issn 0959-4973
issn_str_mv 0959-4973
language English
last_indexed 2024-03-01T14:17:50.144Z
match_str contu1995acomparisonoftheantiemeticefficacyandsafetyofintramuscularandintravenousformulationsofgranisetroninpatientsreceivingmoderatelyemetogenicchemotherapy
mega_collection Ovid Technologies (Wolters Kluwer Health) (CrossRef)
physical 652-656
publishDate 1995
publishDateSort 1995
publisher Ovid Technologies (Wolters Kluwer Health)
record_format ai
recordtype ai
series Anti-Cancer Drugs
source_id 49
spelling Contu, A Olmeo, N Piro, S Sabbatini, R Depenni, R Silingardi, V Zaniboni, A Meriggi, F Donati, D Maestri, A Tateo, S Carpi, A Campora, E Coria, B Riva, E Barbieri, P 0959-4973 Ovid Technologies (Wolters Kluwer Health) Cancer Research Pharmacology (medical) Pharmacology Oncology http://dx.doi.org/10.1097/00001813-199510000-00004 A comparison of the antiemetic efficacy and safety of intramuscular and intravenous formulations of granisetron in patients receiving moderately emetogenic chemotherapy Anti-Cancer Drugs
spellingShingle Contu, A, Olmeo, N, Piro, S, Sabbatini, R, Depenni, R, Silingardi, V, Zaniboni, A, Meriggi, F, Donati, D, Maestri, A, Tateo, S, Carpi, A, Campora, E, Coria, B, Riva, E, Barbieri, P, Anti-Cancer Drugs, A comparison of the antiemetic efficacy and safety of intramuscular and intravenous formulations of granisetron in patients receiving moderately emetogenic chemotherapy, Cancer Research, Pharmacology (medical), Pharmacology, Oncology
title A comparison of the antiemetic efficacy and safety of intramuscular and intravenous formulations of granisetron in patients receiving moderately emetogenic chemotherapy
title_full A comparison of the antiemetic efficacy and safety of intramuscular and intravenous formulations of granisetron in patients receiving moderately emetogenic chemotherapy
title_fullStr A comparison of the antiemetic efficacy and safety of intramuscular and intravenous formulations of granisetron in patients receiving moderately emetogenic chemotherapy
title_full_unstemmed A comparison of the antiemetic efficacy and safety of intramuscular and intravenous formulations of granisetron in patients receiving moderately emetogenic chemotherapy
title_short A comparison of the antiemetic efficacy and safety of intramuscular and intravenous formulations of granisetron in patients receiving moderately emetogenic chemotherapy
title_sort a comparison of the antiemetic efficacy and safety of intramuscular and intravenous formulations of granisetron in patients receiving moderately emetogenic chemotherapy
title_unstemmed A comparison of the antiemetic efficacy and safety of intramuscular and intravenous formulations of granisetron in patients receiving moderately emetogenic chemotherapy
topic Cancer Research, Pharmacology (medical), Pharmacology, Oncology
url http://dx.doi.org/10.1097/00001813-199510000-00004